(Q47705274)

5 February 2018

title

p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. (English)

1 reference

5 February 2018

author name string

L F Qin

1

1 reference

5 February 2018

I O Ng

2

1 reference

5 February 2018

S T Fan

3

1 reference

5 February 2018

M Ng

4

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

5 February 2018

International Journal of Cancer

published in

1 reference

5 February 2018

volume

79

1 reference

5 February 2018

page(s)

424-428

1 reference

5 February 2018

issue

4

1 reference

5 February 2018

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

p21-containing cyclin kinases exist in both active and inactive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

p21(Waf1/Cip1) and p53 protein expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980821%2979%3A4%3C424%3A%3AAID-IJC19%3E3.0.CO%3B2-4

10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9699537

1 reference

5 February 2018